Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3694
-0.0106 (-2.79%)
Aug 13, 2025, 4:00 PM EDT - Market closed
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$768,800
Profits / Employee
-$539,448
Market Cap
84.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VXRT News
- 12 hours ago - Vaxart, Inc. (VXRT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 hours ago - US orders Vaxart to stop COVID-19 trial amid mRNA wind down - Reuters
- 20 days ago - Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq - GlobeNewsWire
- 2 months ago - Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - GlobeNewsWire
- 2 months ago - Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial - GlobeNewsWire
- 2 months ago - Vaxart Announces Adjournment of Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 - GlobeNewsWire